Follow
Alessandra Carobbio
Alessandra Carobbio
Verified email at unimore.it
Title
Cited by
Cited by
Year
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study
A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ...
Leukemia 27 (9), 1874-1881, 2013
8052013
Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ...
Blood, The Journal of the American Society of Hematology 120 (26), 5128-5133, 2012
6482012
Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study.
T Barbui, J Thiele, F Passamonti, E Rumi, E Boveri, M Ruggeri, ...
Journal of clinical oncology 29 (23), 3179-3184, 2011
5722011
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
A Carobbio, J Thiele, F Passamonti, E Rumi, M Ruggeri, F Rodeghiero, ...
Blood, The Journal of the American Society of Hematology 117 (22), 5857-5859, 2011
5062011
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
A Carobbio, G Finazzi, V Guerini, O Spinelli, F Delaini, R Marchioli, ...
Blood 109 (6), 2310-2313, 2007
4342007
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on …
F Passamonti, J Thiele, F Girodon, E Rumi, A Carobbio, H Gisslinger, ...
Blood, The Journal of the American Society of Hematology 120 (6), 1197-1201, 2012
3202012
Thrombosis in primary myelofibrosis: incidence and risk factors
T Barbui, A Carobbio, F Cervantes, AM Vannucchi, P Guglielmelli, ...
Blood, The Journal of the American Society of Hematology 115 (4), 778-782, 2010
3112010
Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial
A Brucato, M Imazio, M Gattorno, G Lazaros, S Maestroni, M Carraro, ...
Jama 316 (18), 1906-1912, 2016
2812016
A pilot study of the Histone‐Deacetylase inhibitor Givinostat in patients with JAK2V617F positive chronic myeloproliferative neoplasms
A Rambaldi, CM Dellacasa, G Finazzi, A Carobbio, ML Ferrari, ...
British journal of haematology 150 (4), 446-455, 2010
2722010
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia
T Barbui, AM Vannucchi, V Buxhofer-Ausch, V De Stefano, S Betti, ...
Blood 126 (23), 4055, 2015
2672015
Leukocytosis and risk stratification assessment in essential thrombocythemia
A Carobbio, E Antonioli, P Guglielmelli, AM Vannucchi, F Delaini, ...
Journal of Clinical Oncology 26 (16), 2732-2736, 2008
2462008
Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts
C Capelli, M Domenghini, G Borleri, P Bellavita, R Poma, A Carobbio, ...
Bone marrow transplantation 40 (8), 785-791, 2007
2162007
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria
G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, M Ruggeri, ...
Leukemia 26 (4), 716-719, 2012
1932012
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3
T Barbui, A Carobbio, G Finazzi, AM Vannucchi, G Barosi, E Antonioli, ...
haematologica 96 (2), 315, 2011
1932011
Masked polycythemia vera (mPV): results of an international study
T Barbui, J Thiele, H Gisslinger, G Finazzi, A Carobbio, E Rumi, ...
American journal of hematology 89 (1), 52-54, 2014
1892014
Masked polycythemia vera (mPV): results of an international study
T Barbui, J Thiele, H Gisslinger, G Finazzi, A Carobbio, E Rumi, ...
American journal of hematology 89 (1), 52-54, 2014
1892014
Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in …
C Tarella, R Passera, M Magni, F Benedetti, A Rossi, A Gueli, C Patti, ...
Journal of Clinical Oncology 29 (7), 814-824, 2011
1752011
The histone deacetylase inhibitor ITF2357 selectively targets cells bearing mutated JAK2V617F
V Guerini, V Barbui, O Spinelli, A Salvi, C Dellacasa, A Carobbio, ...
Leukemia 22 (4), 740-747, 2008
1742008
PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics
D Massi, D Brusa, B Merelli, M Ciano, V Audrito, S Serra, R Buonincontri, ...
Annals of oncology 25 (12), 2433-2442, 2014
1462014
JAK2V617F allele burden and thrombosis: a direct comparison in essential thrombocythemia and polycythemia vera
A Carobbio, G Finazzi, E Antonioli, P Guglielmelli, AM Vannucchi, ...
Experimental hematology 37 (9), 1016-1021, 2009
1432009
The system can't perform the operation now. Try again later.
Articles 1–20